STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
DelistingApr 28, 2026, 05:31 PM

GRDX Receives Nasdaq Delisting Notice for Late 2025 10-K

AI Summary

GridAI Technologies Corp. (GRDX) received a Nasdaq notice on April 22, 2026, for non-compliance with listing rules due to the late filing of its 2025 Form 10-K. The company has 60 days, until June 22, 2026, to submit a compliance plan. If accepted, Nasdaq may grant an extension until October 12, 2026. The delay is attributed to complexities in accounting for a recent acquisition. GRDX plans to file the 10-K and submit a compliance plan promptly, though there's no assurance of Nasdaq's acceptance.

Key Highlights

  • GRDX received Nasdaq notice on April 22, 2026, for non-compliance with Listing Rule 5250(c)(1).
  • Notice is due to the late filing of the Annual Report on Form 10-K for the period ended December 31, 2025.
  • Company has 60 calendar days from April 22, 2026 (until June 22, 2026) to submit a compliance plan.
  • Nasdaq may grant an extension of up to 180 calendar days (until October 12, 2026) if the plan is accepted.
  • Delay in filing 10-K is due to complexity in reviewing accounting for the recent Grid AI Corp. acquisition.
  • GRDX intends to file its 10-K as soon as possible and submit a plan to regain compliance.
  • There is no assurance that Nasdaq will accept the plan or that compliance will be regained.
GRDX
Biotechnology: Pharmaceutical Preparations
GridAI Technologies Corp.

Price Impact